Find published dossiers by topic, company, product or technology.

Showing 161–180 of 189 dossiers

Grafana Agent Observability links live agent telemetry to evals and CI regression gates

The observe–test–release loop now has explicit economics: Free and Pro include 30,000 captured generations and 25 million system-initiated AI tokens per month; Pro overages start at $1.50 per 1,000 generations and $2 per million LLM Eval/Guard tokens, while ordinary telemetry is billed separately.

Amazon SES can now switch open and click tracking per email request

The new request-level controls make email measurement a per-send decision: an application can keep one SES configuration set while disabling open or click tracking for recipients who should not be measured. The override wins over the configuration-set default and adds no separate feature charge.

OpenAI lets one API project choose regional processing per request

OpenAI’s August 21 control moves processing-region choice into request routing: a single Global project can send eligible calls to regional base URLs. That simplifies multi-region SaaS architecture, but builders still need to enforce residency policy in code and account for support, retention and pricing constraints.

DocsBot says better customers are barely offsetting a shrinking signup funnel

The useful small-SaaS lesson is not that SEO is dead or AI search has won. DocsBot’s own numbers show how a channel can remain the largest share of conversions while the total funnel underneath it shrinks, and how 'Direct' can conceal the discovery path that actually influenced a sale.

NVIDIA formally agrees to acquire Hugging Face for $12.93 billion — and promises to keep it open across rival hardware

The previously reported NVIDIA–Hugging Face deal is now a definitive agreement rather than an unconfirmed report. The most important new detail for builders is not only the price: NVIDIA has put multi-model and multi-silicon openness into its public and regulatory framing, while the acquisition still faces closing conditions and regulatory approval.